149281-42-5

Basic information

• Product Name: 6-CHLORO-N-METHOXY-N-METHYL-NICOTINAMIDE
• Synonyms: 6-CHLORO-N-METHOXY-N-METHYL-NICOTINAMIDE;2-Chloro-5-(N-methyl-N-methoxycarbamoyl)pyridine;6-Chloro-N-methoxy-N-methylpyridine-3-carboxamide, 2-Chloro-5-[methoxy(methyl)carbamoyl]pyridine;3-Pyridinecarboxamide, 6-chloro-N-methoxy-N-methyl-
• CAS NO: 149281-42-5
• Molecular Formula: C₈H₉ClN₂O₂
• Molecular Weight: 200.63
• Mol File: 149281-42-5.mol
• Article Data: 31

Chemical Properties

• Boiling Point: 365.346°C at 760 mmHg
• Flash Point: 174.755°C
• Appearance: /
• Density: 1.284g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.544
• Storage Temp.: 2-8°C
• PKA: -2.16±0.10(Predicted)
• CAS DataBase Reference: 6-CHLORO-N-METHOXY-N-METHYL-NICOTINAMIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 6-CHLORO-N-METHOXY-N-METHYL-NICOTINAMIDE(149281-42-5)
• EPA Substance Registry System: 6-CHLORO-N-METHOXY-N-METHYL-NICOTINAMIDE(149281-42-5)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 149281-42-5(Hazardous Substances Data)

Usage

General Description

6-Chloro-N-methoxy-N-methyl-nicotinamide is a chemical compound with the molecular formula C9H10ClN2O2. It is a derivative of nicotinamide and contains a chlorine atom, a methoxy group, and a methyl group attached to the nicotinamide ring. 6-CHLORO-N-METHOXY-N-METHYL-NICOTINAMIDE is used in chemical research and has potential applications in the pharmaceutical industry. It may be used in the synthesis of new drugs or as a starting material for the development of new chemical compounds with biological activity. Additionally, 6-Chloro-N-methoxy-N-methyl-nicotinamide may have properties that make it useful for studying biological processes and mechanisms in the body.

InChI:InChI=1/C8H9ClN2O2/c1-11(13-2)8(12)6-3-4-7(9)10-5-6/h3-5H,1-2H3

Upstream product

• 58757-38-3 6-Chloronicotinoyl chloride 
• 5326-23-8 6-Chloro-3-pyridinecarboxylic acid 
• 16645-06-0 N,N-dimethylhydroxylamine hydrochloride 
• 53939-30-3 5-bromo-2-chloropyridine 
• 15226-74-1 dicobalt octacarbonyl 
• 6638-79-5 N,O-dimethylhydroxylamine*hydrochloride 
• 1117-97-1 N,0-dimethylhydroxylamine 
• 73781-91-6 6-Chloronicotinic acid methyl ester 

Downstream Products

• 490038-59-0 (6-chloro-pyridin-3-yl)-(2,6-difluoro-phenyl)-methanone 
• 112091-17-5 3-(1-methylpyrrolidin-2-yl)-6-chloropyridine 
• 55676-22-7 3-acetyl-6-chloropyridine 
• 862098-75-7 (4-bromo-2,5-difluorophenyl)(6-chloro-3-pyridinyl)methanone 
• 1384869-67-3 (6-chloropyridin-3-yl)(4-(tetrahydro-2H-pyran-2-yloxy)phenyl)methanone 
• 1388824-80-3 (E)-4-(1-(6-chloropyridin-3-yl)-2-phenylbut-1-enyl)phenol 
• 1388824-81-4 (Z)-4-(1-(6-(2-(methylamino)ethoxy)pyridin-3-yl)-2-phenylbut-1-enyl)phenol 
• 1384869-69-5 (6-(3-(pyrrolidin-1-yl)prop-1-ynyl)pyridin-3-yl)(4-(tetrahydro-2H-pyran-2-yloxy)phenyl)methanone 
• 1384869-70-8 (6-(3-(pyrrolidin-1-yl)propyl)pyridin-3-yl)(4-(tetrahydro-2H-pyran-2-yloxy)phenyl)methanone 
• 1388825-99-7 tert-butyl methyl(3-(5-(4-(tetrahydro-2H-pyran-2-yloxy)benzoyl)-pyridin-2-yl)prop-2-ynyl)carbamate 
• 1388826-00-3 tert-butyl methyl(3-(5-(4-(tetrahydro-2H-pyran-2-yloxy)benzoyl)-pyridin-2-yl)propyl)carbamate 
• 1388825-54-4 (Z)-4-(1-(6-(2-(methylamino)ethylthio)pyridin-3-yl)-2-phenylbut-1-enyl)phenol 
• 1388824-77-8 (Z)-4-(1-(6-chloropyridin-3-yl)-2-phenylbut-1-enyl)phenol 
• 872088-03-4 1-(6-chloropyridin-3-yl)propan-1-one 

Relevant articles and documents

Direct synthesis of β-aminoketones from amides via novel sequential nucleophilic substitution/Michael reaction

(formula presented) The synthesis of β-aminoketones from amides can be achieved in a process consisting of sequential nucleophilic substitution at the carbonyl group by vinylmagnesium bromide followed by Michael reaction after quench of the first reaction

PYRIDIN-3-YL ACETIC ACID DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Disclosed are compounds of Formula I, including pharmaceutically acceptable salts, pharmaceutical compositions comprising the compounds, methods for making the compounds and their use in inhibiting HIV integrase and treating those infected with HIV or AIDS. (I)

Discovery of novel 2-[(4-hydroxy-6-oxo-2,3-dihydro-1H-pyridine-5-carbonyl)amino]acetic acid derivatives as HIF prolyl hydroxylase inhibitors for treatment of renal anemia

Prolyl hydroxylase domain-containing protein (PHD) inhibitors are useful as orally administered agents for the treatment of renal anemia. Based on the common structures of known PHD inhibitors, we found novel PHD inhibitor 1 with a 2-[(4-hydroxy-6-oxo-2,3